Remote medical assistance, or telemedicine, may aid a patient in performing various aspects of a rehabilitation regimen for a body part. The patient may use a patient interface in communication with an assistant interface for receiving the remote medical assistance via audio and/or audiovisual communications.
A computer-implemented system is provided. The computer-implemented system comprises a patient interface comprising an output device and an input device. The output device is configured to communicate information to a patient regarding the patient's performance of a treatment plan for the patient. The treatment plan comprises a rehabilitation regimen for a body part comprising at least one of a joint, a bone, or a muscle group. The computer-implemented system also comprises a treatment apparatus configured to be manipulated by the patient for performing the rehabilitation regimen upon the body part. The computer-implemented system also comprises an assistant interface remote from the patient interface and configured to communicate, via a network connection, a telemedicine signal with the patient interface. The telemedicine signal comprises one of an audio signal, an audiovisual signal, an interface control signal for controlling a function of the patient interface, or an apparatus control signal for changing an operating parameter of the treatment apparatus.
A system for remote treatment is also provided. The system for remote treatment comprises a patient interface having an output device and an input device for communicating information to and from a patient. The system for remote treatment also comprises a treatment apparatus configured to be manipulated by the patient for performing a rehabilitation regimen upon the body part, with the body part comprising at least one of a joint, a bone, or a muscle group. The system for remote treatment also comprises an assistant interface configured to communicate a telemedicine signal with the patient interface via a network connection, the telemedicine signal configured to control one of the patient interface or the treatment apparatus. The patient interface and the treatment apparatus are each configured to operate from a patient location geographically separated from the assistant interface.
An assistant user interface generated by a computer is also provided. The assistant user interface comprises an apparatus control having an apparatus status display and an apparatus session control configured to adjust an operating parameter of a treatment apparatus. The treatment apparatus is configured to be manipulated by a patient for performing a rehabilitation regimen upon a body part. The assistant user interface also comprises a patient communications control for controlling an audio or an audiovisual communications session with a patient interface, where the patient interface is configured for use by the patient while performing the rehabilitation regimen upon the body part.
The disclosure is best understood from the following detailed description when read in conjunction with the accompanying drawings. It is emphasized that, according to common practice, the various features of the drawings are not to-scale. On the contrary, the dimensions of the various features are arbitrarily expanded or reduced for clarity.
Various terms are used to refer to particular system components. Different companies may refer to a component by different names—this document does not intend to distinguish between components that differ in name but not function. In the following discussion and in the claims, the terms “including” and “comprising” are used in an open-ended fashion, and thus should be interpreted to mean “including, but not limited to . . . ” Also, the term “couple” or “couples” is intended to mean either an indirect or direct connection. Thus, if a first device couples to a second device, that connection may be through a direct connection or through an indirect connection via other devices and connections.
The terminology used herein is for the purpose of describing particular example embodiments only, and is not intended to be limiting. As used herein, the singular forms “a,” “an,” and “the” may be intended to include the plural forms as well, unless the context clearly indicates otherwise. The method steps, processes, and operations described herein are not to be construed as necessarily requiring their performance in the particular order discussed or illustrated, unless specifically identified as an order of performance. It is also to be understood that additional or alternative steps may be employed.
The terms first, second, third, etc. may be used herein to describe various elements, components, regions, layers and/or sections; however, these elements, components, regions, layers and/or sections should not be limited by these terms. These terms may be only used to distinguish one element, component, region, layer, or section from another region, layer, or section. Terms such as “first,” “second,” and other numerical terms, when used herein, do not imply a sequence or order unless clearly indicated by the context. Thus, a first element, component, region, layer, or section discussed below could be termed a second element, component, region, layer, or section without departing from the teachings of the example embodiments. The phrase “at least one of,” when used with a list of items, means that different combinations of one or more of the listed items may be used, and only one item in the list may be needed. For example, “at least one of: A, B, and C” includes any of the following combinations: A, B, C, A and B, A and C, B and C, and A and B and C. In another example, the phrase “one or more” when used with a list of items means there may be one item or any suitable number of items exceeding one.
Spatially relative terms, such as “inner,” “outer,” “beneath,” “below,” “lower,” “above,” “upper,” “top,” “bottom,” and the like, may be used herein. These spatially relative terms can be used for ease of description to describe one element's or feature's relationship to another element(s) or feature(s) as illustrated in the figures. The spatially relative terms may also be intended to encompass different orientations of the device in use, or operation, in addition to the orientation depicted in the figures. For example, if the device in the figures is turned over, elements described as “below” or “beneath” other elements or features would then be oriented “above” the other elements or features. Thus, the example term “below” can encompass both an orientation of above and below. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptions used herein interpreted accordingly.
Moreover, various functions described below can be implemented or supported by one or more computer programs, each of which is formed from computer readable program code and embodied in a computer readable storage medium. The terms “application” and “program” refer to one or more computer programs, software components, sets of instructions, procedures, functions, methods, objects, classes, instances, related data, or a portion thereof adapted for implementation in a suitable computer readable program code. The phrase “computer readable program code” includes any type of computer code, including source code, object code, and executable code. The phrase “computer readable storage medium” includes any type of medium capable of being accessed by a computer, such as read only memory (ROM), random access memory (RAM), a hard disk drive, a flash drive, a compact disc (CD), a digital video disc (DVD), solid state drive (SSD), or any other type of memory. A “non-transitory” computer readable storage medium excludes wired, wireless, optical, or other communication links that transport transitory electrical or other signals. A non-transitory computer-readable storage medium includes media where data can be permanently stored and media where data can be stored and later overwritten, such as a rewritable optical disc or an erasable memory device.
The terms “transmit,” “receive,” and “communicate,” as well as derivatives thereof, encompass both direct and indirect communication. The terms “transmit,” “receive,” and “communicate,” as well as derivatives thereof, encompass both communication with remote systems and communication within a system, including reading and writing to different portions of a memory device. The term “controller” means any device, system or part thereof that controls at least one operation. Such a controller may be implemented in hardware or a combination of hardware and software and/or firmware. The functionality associated with any particular controller may be centralized or distributed, whether locally or remotely.
A “treatment plan” may include one or more treatment protocols, and each treatment protocol includes one or more treatment sessions. Each treatment session comprises several session periods, with each session period including a particular exercise for treating the body part of the patient. For example, a treatment plan for post-operative rehabilitation after a knee surgery may include an initial treatment protocol with twice daily stretching sessions for the first 3 days after surgery and a more intensive treatment protocol with active exercise sessions performed 4 times per day starting 4 days after surgery. A treatment plan may also include information pertaining to a medical procedure to perform on the patient, a treatment protocol for the patient using a treatment device, a diet regimen for the patient, a medication regimen for the patient, a sleep regimen for the patient, additional regimens, or some combination thereof.
The terms telemedicine, telehealth, telemed, teletherapeutic, telemedicine, etc. may be used interchangeably herein.
The following discussion is directed to various embodiments of the invention. Although one or more of these embodiments may be preferred, the embodiments disclosed should not be interpreted, or otherwise used, as limiting the scope of the disclosure, including the claims. In addition, one skilled in the art will understand that the following description has broad application, and the discussion of any embodiment is meant only to be exemplary of that embodiment, and not intended to intimate that the scope of the disclosure, including the claims, is limited to that embodiment.
The system 10 also includes a server 30 configured to store and to provide data related to managing the treatment plan. The server 30 may include one or more computers and may take the form of a distributed and/or virtualized computer or computers. The server 30 also includes a first communication interface 32 configured to communicate with the clinician interface 20 via a first network 34. In some embodiments, the first network 34 may include wired and/or wireless network connections such as Wi-Fi, Bluetooth, ZigBee, Near-Field Communications (NFC), cellular data network, etc. The server 30 includes a first processor 36 and a first machine-readable storage memory 38, which may be called a “memory” for short, holding first instructions 40 for performing the various actions of the server 30 for execution by the first processor 36. The server 30 is configured to store data regarding the treatment plan. For example, the memory 38 includes a system data store 42 configured to hold system data, such as data pertaining to treatment plans for treating one or more patients. The server 30 is also configured to store data regarding performance by a patient in following a treatment plan. For example, the memory 38 includes a patient data store 44 configured to hold patient data, such as data pertaining to the one or more patients, including data representing each patient's performance within the treatment plan.
The system 10 also includes a patient interface 50 configured to communicate information to a patient and to receive feedback from the patient. Specifically, the patient interface includes an input device 52 and an output device 54, which may be collectively called a patient user interface 52, 54. The input device 52 may include one or more devices, such as a keyboard, a mouse, a touch screen input, a gesture sensor, and/or a microphone and processor configured for voice recognition. The output device 54 may take one or more different forms including, for example, a computer monitor or display screen on a tablet, smartphone, or a smart watch. The output device 54 may include other hardware and/or software components such as a projector, virtual reality capability, augmented reality capability, etc. The output device 54 may incorporate various different visual, audio, or other presentation technologies. For example, the output device 54 may include a non-visual display, such as an audio signal, which may include spoken language and/or other sounds such as tones, chimes, and/or melodies, which may signal different conditions and/or directions. The output device 54 may comprise one or more different display screens presenting various data and/or interfaces or controls for use by the patient. The output device 54 may include graphics, which may be presented by a web-based interface and/or by a computer program or application (App.).
As shown in
The patient interface 50 includes a second processor 60 and a second machine-readable storage memory 62 holding second instructions 64 for execution by the second processor 60 for performing various actions of patient interface 50. The second machine-readable storage memory 62 also includes a local data store 66 configured to hold data, such as data pertaining to a treatment plan and/or patient data, such as data representing a patient's performance within a treatment plan. The patient interface 50 also includes a local communication interface 68 configured to communicate with various devices for use by the patient in the vicinity of the patient interface 50. The local communication interface 68 may include wired and/or wireless communications. In some embodiments, the local communication interface 68 may include a local wireless network such as Wi-Fi, Bluetooth, ZigBee, Near-Field Communications (NFC), cellular data network, etc.
The system 10 also includes a treatment apparatus 70 configured to be manipulated by the patient and/or to manipulate a body part of the patient for performing activities according to the treatment plan. In some embodiments, the treatment apparatus 70 may take the form of an exercise and rehabilitation apparatus configured to perform and/or to aid in the performance of a rehabilitation regimen, which may be an orthopedic rehabilitation regimen, and the treatment includes rehabilitation of a body part of the patient, such as a joint or a bone or a muscle group. The body part may include, for example, a spine, a hand, a foot, a knee, or a shoulder. The body part may include a part of a joint, a bone, or a muscle group, such as one or more vertebrae, a tendon, or a ligament. As shown in
The internal sensors 76 may measure one or more operating characteristics of the treatment apparatus 70 such as, for example, a force a position, a speed, and/or a velocity. In some embodiments, the internal sensors 76 may include a position sensor configured to measure at least one of a linear motion or an angular motion of a body part of the patient. For example, an internal sensor 76 in the form of a position sensor may measure a distance that the patient is able to move a part of the treatment apparatus 70, where such distance may correspond to a range of motion that the patient's body part is able to achieve. In some embodiments, the internal sensors 76 may include a force sensor configured to measure a force applied by the patient. For example, an internal sensor 76 in the form of a force sensor may measure a force or weight the patient is able to apply, using a particular body part, to the treatment apparatus 70.
The system 10 shown in
The system 10 shown in
The system 10 shown in
The system 10 shown in
The system 10 shown in
The system 10 includes an assistant interface 94 for an assistant, such as a doctor, a nurse, a physical therapist, or a technician, to remotely communicate with the patient interface 50 and/or the treatment apparatus 70. Such remote communications may enable the assistant to provide assistance or guidance to a patient using the system 10. More specifically, the assistant interface 94 is configured to communicate a telemedicine signal 96, 97, 98a, 98b, 99a, 99b with the patient interface 50 via a network connection such as, for example, via the first network 34 and/or the second network 58. The telemedicine signal 96, 97, 98a, 98b, 99a, 99b comprises one of an audio signal 96, an audiovisual signal 97, an interface control signal 98a for controlling a function of the patient interface 50, an interface monitor signal 98b for monitoring a status of the patient interface 50, an apparatus control signal 99a for controlling the treatment apparatus 70 (e.g., by changing an operating parameter (a speed of the motor, a resistive force of the pedals, a degree of motion provided by the pedal(s), etc.) of the treatment apparatus 70), an environmental change signal for controlling another electronic device (e.g., thermostat, speaker, light, door, appliance, etc.) that is proximate (e.g., within the same physical space) to the treatment apparatus 70 and/or the patient interface 50, and/or an apparatus monitor signal 99b for monitoring a status of the treatment apparatus 70. In some embodiments, the environmental change signal may cause the electronic device to change a temperature, change an air pressure, change an ambient setting, change an audio setting, etc. In some embodiments, each of the control signals 98a, 99a may be unidirectional, conveying commands from the assistant interface 94 to the patient interface 50. In some embodiments, in response to successfully receiving a control signal 98a, 99a and/or to communicate successful and/or unsuccessful implementation of the requested control action, an acknowledgement message may be sent from the patient interface 50 to the assistant interface 94. In some embodiments, each of the monitor signals 98b, 99b may be unidirectional, status-information commands from the patient interface 50 to the assistant interface 94. In some embodiments, an acknowledgement message may be sent from the assistant interface 94 to the patient interface 50 in response to successfully receiving one of the monitor signals 98b, 99b.
In some embodiments, the patient interface 50 may be configured as a pass-through for the apparatus control signals 99a and the apparatus monitor signals 99b between the treatment apparatus 70 and one or more other devices, such as the assistant interface 94 and/or the server 30. For example, the patient interface 50 may be configured to transmit an apparatus control signal 99a in response to an apparatus control signal 99a within the telemedicine signal 96, 97, 98a, 98b, 99a, 99b from the assistant interface 94.
In some embodiments, the assistant interface 94 may be presented on a shared physical device as the clinician interface 20. For example, the clinician interface 20 may include one or more screens that implement the assistant interface 94. Alternatively or additionally, the clinician interface 20 may include additional hardware components, such as a video camera, a speaker, and/or a microphone, to implement aspects of the assistant interface 94.
In some embodiments, one or more portions of the telemedicine signal 96, 97, 98a, 98b, 99a, 99b may be generated from a prerecorded source (e.g., an audio recording, a video recording, or an animation) for presentation by the output device 54 of the patient interface 50. For example, a tutorial video may be streamed from the server 30 and presented upon the patient interface 50. Content from the prerecorded source may be requested by the patient via the patient interface 50. Alternatively, via a control on the assistant interface 94, the assistant may cause content from the prerecorded source to be played on the patient interface 50.
The assistant interface 94 includes an assistant input device 22 and an assistant display 24, which may be collectively called an assistant user interface 22, 24. The assistant input device 22 may include one or more of a telephone, a keyboard, a mouse, a trackpad, or a touch screen, for example. Alternatively or additionally, the assistant input device 22 may include one or more microphones. In some embodiments, the one or more microphones may take the form of a telephone handset, headset, or wide-area microphone or microphones configured for the assistant to speak to a patient via the patient interface 50. In some embodiments, assistant input device 22 may be configured to provide voice-based functionalities, with hardware and/or software configured to interpret spoken instructions by the assistant by using the one or more microphones. The assistant input device 22 may include functionality provided by or similar to existing voice-based assistants such as Siri by Apple, Alexa by Amazon, Google Assistant, or Bixby by Samsung. The assistant input device 22 may include other hardware and/or software components. The assistant input device 22 may include one or more general purpose devices and/or special-purpose devices.
The assistant display 24 may take one or more different forms including, for example, a computer monitor or display screen on a tablet, a smartphone, or a smart watch. The assistant display 24 may include other hardware and/or software components such as projectors, virtual reality capabilities, or augmented reality capabilities, etc. The assistant display 24 may incorporate various different visual, audio, or other presentation technologies. For example, the assistant display 24 may include a non-visual display, such as an audio signal, which may include spoken language and/or other sounds such as tones, chimes, melodies, and/or compositions, which may signal different conditions and/or directions. The assistant display 24 may comprise one or more different display screens presenting various data and/or interfaces or controls for use by the assistant. The assistant display 24 may include graphics, which may be presented by a web-based interface and/or by a computer program or application (App.).
In some embodiments, the system 10 may provide computer translation of language from the assistant interface 94 to the patient interface 50 and/or vice-versa. The computer translation of language may include computer translation of spoken language and/or computer translation of text. Additionally or alternatively, the system 10 may provide voice recognition and/or spoken pronunciation of text. For example, the system 10 may convert spoken words to printed text and/or the system 10 may audibly speak language from printed text. The system 10 may be configured to recognize spoken words by any or all of the patient, the clinician, and/or the assistant. In some embodiments, the system 10 may be configured to recognize and react to spoken requests or commands by the patient. For example, the system 10 may automatically initiate a telemedicine session in response to a verbal command by the patient (which may be given in any one of several different languages).
In some embodiments, the server 30 may generate aspects of the assistant display 24 for presentation by the assistant interface 94. For example, the server 30 may include a web server configured to generate the display screens for presentation upon the assistant display 24. In some embodiments, the assistant display 24 may be configured to present a virtualized desktop hosted by the server 30. In some embodiments, the server 30 may be configured to communicate with the assistant interface 94 via the first network 34. In some embodiments, the first network 34 may include a local area network (LAN), such as an Ethernet network. In some embodiments, the first network 34 may include the Internet, and communications between the server 30 and the assistant interface 94 may be secured via privacy enhancing technologies, such as, for example, by using encryption over a virtual private network (VPN). Alternatively or additionally, the server 30 may be configured to communicate with the assistant interface 94 via one or more networks independent of the first network 34 and/or other communication means, such as a direct wired or wireless communication channel. In some embodiments, the patient interface 50 and the treatment apparatus 70 may each operate from a patient location geographically separate from a location of the assistant interface 94. For example, the patient interface 50 and the treatment apparatus 70 may be used as part of an in-home rehabilitation system, which may be aided remotely by using the assistant interface 94 at a centralized location, such as a clinic or a call center.
In some embodiments, the assistant interface 94 may be one of several different terminals that may be grouped together, for example, in one or more call centers or at one or more clinicians' offices. In some embodiments, a plurality of assistant interfaces 94 may be distributed geographically. In some embodiments, a person may work as an assistant remotely from any conventional office infrastructure. Such remote work may be performed, for example, where the assistant interface 94 takes the form of a computer and/or telephone. This remote work functionality may allow for work-from-home arrangements that may include part time and/or flexible work hours for an assistant.
Specifically, the overview display 120 includes a patient profile display 130 presenting biographical information regarding a patient using the treatment apparatus. The patient profile display 130 may take the form of a portion or region of the overview display 120, as shown in
The example overview display 120 shown in
User access controls may be used to limit access, including what data is available to be viewed and/or modified, on any or all of the user interfaces 20, 50, 90, 92, 94 of the system 10. In some embodiments, user access controls may be employed to control what information is available to any given person using the system 10. For example, data presented on the assistant interface 94 may be controlled by user access controls, with permissions set depending on the assistant/user's need for and/or qualifications to view that information.
The example overview display 120 shown in
The example overview display 120 shown in
In some embodiments, the patient interface setting control 154 may include collaborative browsing or co-browsing capability for the assistant to remotely view and/or control the patient interface 50. For example, the patient interface setting control 154 may enable the assistant to remotely enter text to one or more text entry fields on the patient interface 50 and/or to remotely control a cursor on the patient interface 50 using a mouse or touchscreen of the assistant interface 94.
In some embodiments, using the patient interface 50, the patient interface setting control 154 may allow the assistant to change a setting that cannot be changed by the patient. For example, the patient interface 50 may be precluded from accessing a language setting to prevent a patient from inadvertently switching, on the patient interface 50, the language used for the displays, whereas the patient interface setting control 154 may enable the assistant to change the language setting of the patient interface 50. In another example, the patient interface 50 may not be able to change a font size setting to a smaller size in order to prevent a patient from inadvertently switching the font size used for the displays on the patient interface 50 such that the display would become illegible to the patient, whereas the patient interface setting control 154 may provide for the assistant to change the font size setting of the patient interface 50.
The example overview display 120 shown in
The example overview display 120 shown in
The apparatus control 160 may include an apparatus setting control 164 for the assistant to adjust or control one or more aspects of the treatment apparatus 70. The apparatus setting control 164 may cause the assistant interface 94 to generate and/or to transmit an apparatus control signal 99 for changing an operating parameter of the treatment apparatus 70, (e.g., a pedal radius setting, a resistance setting, a target RPM, etc.). The apparatus setting control 164 may include a mode button 166 and a position control 168, which may be used in conjunction for the assistant to place an actuator 78 of the treatment apparatus 70 in a manual mode, after which a setting, such as a position or a speed of the actuator 78, can be changed using the position control 168. The mode button 166 may provide for a setting, such as a position, to be toggled between automatic and manual modes. In some embodiments, one or more settings may be adjustable at any time, and without having an associated auto/manual mode. In some embodiments, the assistant may change an operating parameter of the treatment apparatus 70, such as a pedal radius setting, while the patient is actively using the treatment apparatus 70. Such “on the fly” adjustment may or may not be available to the patient using the patient interface 50. In some embodiments, the apparatus setting control 164 may allow the assistant to change a setting that cannot be changed by the patient using the patient interface 50. For example, the patient interface 50 may be precluded from changing a preconfigured setting, such as a height or a tilt setting of the treatment apparatus 70, whereas the apparatus setting control 164 may provide for the assistant to change the height or tilt setting of the treatment apparatus 70.
The example overview display 120 shown in
In some embodiments, the audio or an audiovisual communications session with the patient interface 50 may take place, at least in part, while the patient is performing the rehabilitation regimen upon the body part. The patient communications control 170 may take the form of a portion or region of the overview display 120, as shown in
The example overview display 120 shown in
In some embodiments, an operator or dispatcher may receive an initial request for assistance from the patient interface 50. The operator or dispatcher may forward the request for assistance to an assistant available and/or to an assistant qualified or suited to help the patient with a particular problem or inquiry. For example, medical questions regarding the patient's body may be forwarded to an assistant having medical qualifications, such as a doctor or a nurse. Technical questions regarding operation or use of the treatment apparatus 70 may be forwarded to a technician having training and/or experience with the treatment apparatus 70. In some embodiments, the operator or dispatcher may be equipped and authorized to answer some questions that are frequently asked and/or which do not require specialized knowledge or training.
The help screen 560 may also include an exit button 564 that the patient can use to stop the treatment session in case they are unable to resolve their issue with using the treatment apparatus 70. Use of the exit button 564 may generate an alert to the clinician. The help screen 560 also includes a proceed button 566 that the patient can use to indicate that they have resolved their issue and are able to proceed with the treatment session.
In some embodiments, a telemedicine session with the assistant interface may be initiated by the patient interface 50 in response to a predetermined condition of the treatment apparatus 70. For example, if a patient is unable to meet certain performance criteria, such as RPM or a force upon one of the pedals, or if the patient's performance of an activity using the treatment apparatus 70 is outside of normal use by that patient, then the system 10 may be configured to automatically initiate the telemedicine session wherein an assistant checks to see if the patient needs help.
For simplicity of explanation, the method 900 is depicted and described as a series of operations. However, operations in accordance with this disclosure can occur in various orders and/or concurrently, and with other operations not presented and described herein. For example, the operations depicted in the method 900 may occur in combination with any other operation of any other method disclosed herein. Furthermore, not all illustrated operations may be required to implement the method 900 in accordance with the disclosed subject matter. In addition, those skilled in the art will understand and appreciate that the method 900 could alternatively be represented as a series of interrelated states via a state diagram or events.
At 902, the processing device may receive, at the patient interface 50, data from one or more sources. In some embodiments, the one or more sources may include a sensor (e.g., pressure or force sensor, goniometer, wearable sensor, etc.), the treatment apparatus 70, an input peripheral (e.g., touchscreen, mouse, keyboard, microphone, camera, etc.) of the patient interface 50, or some combination thereof. In some embodiments, the data may include a sensor measurement (e.g., force measurement from a pressure sensor of the pedal, a range of motion measurement from the goniometer, a vital sign from a wearable, a temperature of the patient from a thermometer, etc.), an answer (e.g., a pain level, whether the exercise is too difficult, etc.) to a question presented on the patient interface 50, a vital sign (e.g., heartrate, blood pressure, etc.), a characteristic of the user, or some combination thereof.
The data may be received while a user (patient) is operating the treatment apparatus 70 to perform a treatment plan. The treatment plan may include a rehabilitation regimen for a body part. In some embodiments, the body part may include at least one of a joint, a bone, a ligament, a tendon, or a muscle group.
At 904, the processing device may determine, based on the data, whether a trigger event has occurred. In some embodiments, the trigger event may include receiving a response to one or more questions presented on the patient interface 50, where the response is an answer to the one or more questions. In some embodiments, the trigger event may include determining a condition of the treatment apparatus 70 (e.g., the patient is not exerting a threshold level of force on the pressure sensor of the pedal, the patient is not able to pedal at a particular range of motion setting, etc.).
At 906, responsive to determining the trigger event has occurred and using the patient interface 50 and the assistant interface 94, the processing device may electronically initiate the telemedicine session. Initiating the telemedicine session may include two-way communication between the patient interface 50 and the assistant interface 94 that triggers an application installed as a stand-alone application or within another application (e.g., website in a web browser) on each of the patient interface 50 and assistant interface 94 to execute computer instructions. The execution of the computer instructions may control the application to initiate the telemedicine session, where the telemedicine session can include audio, visual, audiovisual, or the like. In some embodiments, a portion of a user interface of the application executing on the assistant interface 94 and the patient interface 50 may present a video feed of each respective participant (e.g., the patient feed is presented on the assistant interface 94 and the assistant feed is presented on the patient interface 50).
In some embodiments, the processing device may cause presentation of the data on the assistant interface 94 by transmitting the data to the assistant interface 94. In some embodiments, the processing device may receive, from the assistant interface 94, a telemedicine signal including one of an audio signal, an audiovisual signal, a visual signal, a haptic signal, an environmental change signal, an interface control signal for controlling a function of the patient interface 50, or an apparatus control signal for changing an operating parameter of the treatment apparatus 70.
In some embodiments, the processing device may cause, during the telemedicine session, a patient profile display to be presented on the assistant interface 94. The patient profile display may include information related to the treatment plan for the patient, and the treatment plan may be related to how the patient is intended to use the treatment apparatus.
Any of the systems and methods described in this disclosure may be used in connection with rehabilitation. Rehabilitation may be directed at cardiac rehabilitation, rehabilitation from stroke, multiple sclerosis, Parkinson's disease, a brain injury, a spinal cord injury, a spinal cord disease, a joint injury, a joint disease, or the like. Rehabilitation can further involve muscular contraction improving blood flow and lymphatic flow, engaging the brain and nervous system to control and affect a traumatized area to increase the speed of healing, reversing or reducing pain, reversing or reducing stiffness, recovering range of motion, cardiovascular engagement to stimulate the release of pain blocking hormones and encourage freshly oxygenated blood flow to aid in an overall feeling of well-being. Rehabilitation may be provided for individuals of average height in reasonably good physical condition having no substantial deformities, as well as individuals more typically in need of rehabilitation, such as those that are elderly, obese, injured and/or have a severely limited range of motion. Unless expressly stated otherwise, is to be understood that rehabilitation includes prehabilitation (also referred to as “prehabilitation” or “prehab”). Prehabilitation may be used as a preventative procedure or as a pre-surgical or pre-treatment procedure. Prehabilitation may include any action performed by or on a patient (or directed to be performed by or on a patient, including, without limitation, remotely or distally through telemedicine) to, without limitation, prevent or reduce a likelihood of injury (e.g., prior to the occurrence of the injury); improve recovery time subsequent to surgery; improve strength subsequent to surgery; or any of the foregoing with respect to any non-surgical clinical treatment plan to be undertaken for the purpose of ameliorating or mitigating injury, dysfunction, or other negative consequence of surgical or non-surgical treatment on any external or internal part of a patient's body. For example, a mastectomy may require prehabilitation to strengthen muscles or muscle groups affected directly or indirectly by the mastectomy. As a further non-limiting example, the removal of an intestinal tumor, the repair of a hernia, open-heart surgery or other procedures performed on internal organs or structures, whether to repair those organs or structures, to excise them or parts of them, to treat them, etc., can require cutting through and harming numerous muscles and muscle groups in or about, without limitation, the abdomen, the ribs and/or the thoracic cavity. Prehabilitation can improve a patient's speed of recovery, measure of quality of life, level of pain, etc. in all the foregoing procedures. In one embodiment of prehabilitation, a pre-surgical procedure or a pre-non-surgical-treatment may include one or more sets of exercises for a patient to perform prior to such procedure or treatment. Performance of the one or more sets of exercises may be required in order to qualify for an elective surgery, such as a knee replacement. The patient may prepare an area of his or her body for the surgical procedure by performing the one or more sets of exercises, thereby strengthening muscle groups, improving existing muscle memory, reduce pain, reduce stiffness, establishing new muscle memory, enhancing mobility (i.e., improve range of motion), improving blood flow, and/or the like.
In some embodiments, the systems and methods described herein may use artificial intelligence and/or machine learning to generate the treatment plan for a user. Additionally, or alternatively, the systems and methods described herein may use artificial intelligence and/or machine learning to recommend an optimal exercise machine configuration for a user. Additionally, or alternatively, the systems and methods described herein may use artificial intelligence and/or machine learning to control the treatment apparatus during a telemedicine session or not during the telemedicine session. an optimal exercise machine configuration for a user.
Consistent with the above disclosure, the examples of assemblies enumerated in the following clauses are specifically contemplated and are intended as a non-limiting set of examples.
1. A computer-implemented system, comprising: a patient interface comprising an output device and an input device, the output device configured to communicate information to a patient regarding the patient's performance of a treatment plan for the patient, the treatment plan comprising a rehabilitation regimen for a body part; a treatment apparatus configured to be manipulated by the patient for performing the rehabilitation regimen upon the body part; an assistant interface remote from the patient interface and configured to communicate, via a network connection, a telemedicine signal to the patient interface; wherein the telemedicine signal comprises one of an audio signal, an audiovisual signal, a visual signal, a haptic signal, an environmental change signal, an interface control signal for controlling a function of the patient interface, or an apparatus control signal for changing an operating parameter of the treatment apparatus.
2. The computer-implemented system of claim 1, wherein the one of the audio signal, the audiovisual signal, the visual signal, the haptic signal, or the environmental change signal includes a feed from the assistant interface, and the feed is configured to be presented by the output device of the patient interface.
3. The computer-implemented system of claim 1, wherein the telemedicine signal is generated from a prerecorded source, and the telemedicine signal is configured to be presented by the output device of the patient interface.
4. The computer-implemented system of claim 1, wherein the patient interface is configured to transmit an apparatus monitor signal to the assistant interface, and the apparatus monitor signal includes status information related to the treatment apparatus.
5. The computer-implemented system of claim 1, wherein, to effect a change to an operating parameter of the treatment apparatus, the telemedicine signal is configured to comprise the apparatus control signal from the assistant interface.
6. The computer-implemented system of claim 1, wherein the patient interface is configured to provide two-way audio communications, two-way audiovisual communications, two-way visual communications, two-way haptic communications, two-way environmental communications with a person using the assistant interface, or two-way communications using on each side of the communications one of the foregoing means, where the means on one side and the means on the other side are different.
7. The computer-implemented system of claim 1, wherein the patient interface includes a manual control such that the patient uses the assistant interface to initiate a telemedicine session.
8. The computer-implemented system of claim 1, wherein the patient interface is configured to solicit answers to one or more questions from the patient; and wherein predetermined answers to the one or more questions are configured to enable a telemedicine session to be initiated, wherein the telemedicine session uses the assistant interface.
9. The computer-implemented system of claim 1, wherein a predetermined condition of the treatment apparatus causes the patient interface to initiate a telemedicine session, wherein the telemedicine session uses the assistant interface.
10. The computer-implemented system of claim 1, further comprising a clinician interface, wherein such interface includes a protocol management display presenting controls for modifying a treatment protocol within the treatment plan; and wherein the assistant interface is presented on a physical device shared with the clinician interface.
11. The computer-implemented system of claim 1, further comprising a server computer configured to store data related to one of the treatment plan or the patient; and wherein the assistant interface is configured to be in communication with a server for receiving the data related to the one of the treatment plan or the patient.
12. The computer-implemented system of claim 1, wherein the body part comprises at least one of a joint, a bone, a ligament, a tendon, or a muscle group.
13. A system for remote treatment, comprising: a patient interface comprising an output device and an input device for communicating information to and from a patient; a treatment apparatus configured to be manipulated by the patient for performing a rehabilitation regimen upon a body part; an assistant interface configured to communicate a telemedicine signal with the patient interface via a network connection, the telemedicine signal configured to control one of the patient interface or the treatment apparatus; and wherein the patient interface and the treatment apparatus are each configured to operate from a patient location geographically separated from the assistant interface.
14. The system of claim 13, wherein the assistant interface includes a control for changing a setting of one of the patient interface or the treatment apparatus; and wherein the assistant interface is configured to change the setting of the one of the patient interface or the treatment apparatus when the setting cannot be changed by the patient using the patient interface.
15. The system of claim 13, wherein the patient interface is configured to transmit a control signal to the treatment apparatus in response to receiving the telemedicine signal from the assistant interface.
16. The system of claim 13, wherein the body part comprises at least one of a joint, a bone, a ligament, a tendon, or a muscle group.
17. An assistant user interface generated by a computer and comprising: an apparatus control comprising an apparatus status display and an apparatus session control, the apparatus session control configured to adjust an operating parameter of a treatment apparatus, the treatment apparatus configured to be manipulated by a patient for performing a rehabilitation regimen upon a body part; a patient communications control for controlling an audio or an audiovisual communications session with a patient interface, the patient interface configured for use by the patient such that the patient is able to perform the rehabilitation regimen upon the body part.
18. The assistant user interface of claim 17, further comprising a patient interface control presenting information related to the patient interface.
19. The assistant user interface of claim 18, wherein the information related to the patient interface comprises an image presented on a display screen of the patient interface.
20. The assistant user interface of claim 18, wherein the patient interface control further includes a setting control for adjusting a setting of the patient interface.
21. The assistant user interface of claim 17, further comprising a patient profile display presenting biographical information related to the patient using the treatment apparatus.
22. The assistant user interface of claim 17, further comprising a patient profile display presenting information related to a treatment plan for the patient, wherein the treatment plan is related to how the patient is intended to use the treatment apparatus.
23. A method for initiating a telemedicine session using an assistant interface and a patient interface, the method comprising: receiving, at the patient interface, data from one or more sources, wherein the data is received while a user is operating a treatment apparatus to perform a treatment plan, the treatment plan comprising a rehabilitation regimen for a body part; determining, based on the data, whether a trigger event has occurred; and responsive to determining the trigger event has occurred, using the patient interface and the assistant interface to electronically initiate the telemedicine session.
24. The method of claim 23, further comprising: causing presentation of the data on the assistant interface; and receiving, from the assistant interface, a telemedicine signal comprising one of an audio signal, an audiovisual signal, a visual signal, a haptic signal, an environmental change signal, an interface control signal for controlling a function of the patient interface, or an apparatus control signal for changing an operating parameter of the treatment apparatus.
25. The method of claim 23, wherein the one or more sources comprise a sensor, the treatment apparatus, an input peripheral of the patient interface, or some combination thereof.
26. The method of claim 23, wherein the data comprises a sensor measurement, an answer to a question presented on the patient interface, a vital sign, a characteristic of the user, or some combination thereof.
27. The method of claim 23, wherein the trigger event comprises receiving a response to one or more questions presented on the patient interface.
28. The method of claim 23, wherein the trigger event comprises determining a condition of the treatment apparatus.
29. The method of claim 23, wherein the body part comprises at least one of a joint, a bone, a ligament, a tendon, or a muscle group.
30. The method of claim 23, further causing, during the telemedicine session, a patient profile display to be presented on the assistant interface, wherein the patient profile display comprises information related to the treatment plan for the patient, and the treatment plan is related to how the patient is intended to use the treatment apparatus.
The above discussion is meant to be illustrative of the principles and various embodiments of the present invention. Numerous variations and modifications will become apparent to those skilled in the art once the above disclosure is fully appreciated. It is intended that the following claims be interpreted to embrace all such variations and modifications.
The various aspects, embodiments, implementations, or features of the described embodiments can be used separately or in any combination. The embodiments disclosed herein are modular in nature and can be used in conjunction with or coupled to other embodiments.
Consistent with the above disclosure, the examples of assemblies enumerated in the following clauses are specifically contemplated and are intended as a non-limiting set of examples.
This application is a continuation of U.S. patent application Ser. No. 17/021,895, filed Sep. 15, 2020, titled “Telemedicine for Orthopedic Treatment”, which claims priority to and the benefit of U.S. Provisional Patent Application Ser. No. 62/910,232 filed Oct. 3, 2019, titled “Telemedicine for Orthopedic Treatment”, the entire disclosures of which are hereby incorporated by reference for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
4822032 | Whitmore et al. | Apr 1989 | A |
4860763 | Schminke | Aug 1989 | A |
4932650 | Bingham et al. | Jun 1990 | A |
5137501 | Mertesdorf | Aug 1992 | A |
5240417 | Smithson et al. | Aug 1993 | A |
5256117 | Potts et al. | Oct 1993 | A |
5284131 | Gray | Feb 1994 | A |
5356356 | Hildebrandt | Oct 1994 | A |
D359777 | Hildebrandt | Jun 1995 | S |
5429140 | Burdea et al. | Jul 1995 | A |
5738636 | Saringer et al. | Apr 1998 | A |
6007459 | Burgess | Dec 1999 | A |
D421075 | Hildebrandt | Feb 2000 | S |
6110130 | Kramer | Aug 2000 | A |
6162189 | Girone et al. | Dec 2000 | A |
6182029 | Friedman | Jan 2001 | B1 |
6267735 | Blanchard et al. | Jul 2001 | B1 |
6273863 | Avni et al. | Aug 2001 | B1 |
6413190 | Wood et al. | Jul 2002 | B1 |
6436058 | Krahner et al. | Aug 2002 | B1 |
6450923 | Vatti | Sep 2002 | B1 |
6491649 | Ombrellaro | Dec 2002 | B1 |
6514085 | Slattery et al. | Feb 2003 | B2 |
6535861 | OConnor et al. | Mar 2003 | B1 |
6601016 | Brown et al. | Jul 2003 | B1 |
6602191 | Quy | Aug 2003 | B2 |
6613000 | Reinkensmeyer et al. | Sep 2003 | B1 |
6626800 | Casler | Sep 2003 | B1 |
6626805 | Lightbody | Sep 2003 | B1 |
6652425 | Martin et al. | Nov 2003 | B1 |
6902513 | McClure | Jun 2005 | B1 |
7058453 | Nelson et al. | Jun 2006 | B2 |
7063643 | Arai | Jun 2006 | B2 |
7156665 | OConnor et al. | Jan 2007 | B1 |
7156780 | Fuchs et al. | Jan 2007 | B1 |
7169085 | Killin et al. | Jan 2007 | B1 |
7209886 | Kimmel | Apr 2007 | B2 |
7226394 | Johnson | Jun 2007 | B2 |
RE39904 | Lee | Oct 2007 | E |
7507188 | Nurre | Mar 2009 | B2 |
7594879 | Johnson | Sep 2009 | B2 |
7628730 | Watterson et al. | Dec 2009 | B1 |
D610635 | Hildebrandt | Feb 2010 | S |
7778851 | Schoenberg et al. | Aug 2010 | B2 |
7809601 | Shaya et al. | Oct 2010 | B2 |
7815551 | Merli | Oct 2010 | B2 |
7833135 | Radow et al. | Nov 2010 | B2 |
7837472 | Elsmore et al. | Nov 2010 | B1 |
7955219 | Birrell et al. | Jun 2011 | B2 |
7969315 | Ross et al. | Jun 2011 | B1 |
7974689 | Volpe et al. | Jul 2011 | B2 |
7988599 | Ainsworth et al. | Aug 2011 | B2 |
8012107 | Einav et al. | Sep 2011 | B2 |
8021270 | D'Eredita | Sep 2011 | B2 |
8038578 | Olrik et al. | Oct 2011 | B2 |
8079937 | Bedell | Dec 2011 | B2 |
8113991 | Kutliroff | Feb 2012 | B2 |
8177732 | Einav et al. | May 2012 | B2 |
8287434 | Zavadsky et al. | Oct 2012 | B2 |
8298123 | Hickman | Oct 2012 | B2 |
8371990 | Shea | Feb 2013 | B2 |
8419593 | Ainsworth et al. | Apr 2013 | B2 |
8465398 | Lee et al. | Jun 2013 | B2 |
8506458 | Dugan | Aug 2013 | B2 |
8515777 | Rajasenan | Aug 2013 | B1 |
8540515 | Williams et al. | Sep 2013 | B2 |
8540516 | Williams et al. | Sep 2013 | B2 |
8556778 | Dugan | Oct 2013 | B1 |
8607465 | Edwards | Dec 2013 | B1 |
8613689 | Dyer et al. | Dec 2013 | B2 |
8672812 | Dugan | Mar 2014 | B2 |
8751264 | Beraja et al. | Jun 2014 | B2 |
8784273 | Dugan | Jul 2014 | B2 |
8818496 | Dziubinski et al. | Aug 2014 | B2 |
8823448 | Shen | Sep 2014 | B1 |
8845493 | Watterson et al. | Sep 2014 | B2 |
8849681 | Hargrove et al. | Sep 2014 | B2 |
8864628 | Boyette et al. | Oct 2014 | B2 |
8893287 | Gjonej et al. | Nov 2014 | B2 |
8911327 | Boyette | Dec 2014 | B1 |
8979711 | Dugan | Mar 2015 | B2 |
9004598 | Weber | Apr 2015 | B2 |
9248071 | Brenda | Feb 2016 | B1 |
9272185 | Dugan | Mar 2016 | B2 |
9283434 | Wu | Mar 2016 | B1 |
9311789 | Gwin | Apr 2016 | B1 |
9312907 | Auchinleck et al. | Apr 2016 | B2 |
9367668 | Flynt et al. | Jun 2016 | B2 |
9409054 | Dugan | Aug 2016 | B2 |
9443205 | Wall | Sep 2016 | B2 |
9474935 | Abbondanza et al. | Oct 2016 | B2 |
9481428 | Gros | Nov 2016 | B2 |
9514277 | Hassing et al. | Dec 2016 | B2 |
9566472 | Dugan | Feb 2017 | B2 |
9629558 | Yuen et al. | Apr 2017 | B2 |
9640057 | Ross | May 2017 | B1 |
9707147 | Levital et al. | Jul 2017 | B2 |
D794142 | Zhou | Aug 2017 | S |
9717947 | Lin | Aug 2017 | B2 |
9737761 | Govindarajan | Aug 2017 | B1 |
9757612 | Weber | Sep 2017 | B2 |
9782621 | Chiang et al. | Oct 2017 | B2 |
9802076 | Murray et al. | Oct 2017 | B2 |
9802081 | Ridgel et al. | Oct 2017 | B2 |
9813239 | Chee et al. | Nov 2017 | B2 |
9827445 | Marcos et al. | Nov 2017 | B2 |
9849337 | Roman et al. | Dec 2017 | B2 |
9868028 | Shin | Jan 2018 | B2 |
9872087 | DelloStritto et al. | Jan 2018 | B2 |
9872637 | Kording et al. | Jan 2018 | B2 |
9914053 | Dugan | Mar 2018 | B2 |
9919198 | Romeo et al. | Mar 2018 | B2 |
9937382 | Dugan | Apr 2018 | B2 |
9939784 | Berardinelli | Apr 2018 | B1 |
9977587 | Mountain | May 2018 | B2 |
9993181 | Ross | Jun 2018 | B2 |
10004946 | Ross | Jun 2018 | B2 |
D826349 | Oblamski | Aug 2018 | S |
10055550 | Goetz | Aug 2018 | B2 |
10058473 | Oshima et al. | Aug 2018 | B2 |
10089443 | Miller et al. | Oct 2018 | B2 |
10111643 | Shulhauser et al. | Oct 2018 | B2 |
10130298 | Mokaya et al. | Nov 2018 | B2 |
10130311 | De Sapio et al. | Nov 2018 | B1 |
10137328 | Baudhuin | Nov 2018 | B2 |
10143395 | Chakravarthy et al. | Dec 2018 | B2 |
10155134 | Dugan | Dec 2018 | B2 |
10159872 | Sasaki et al. | Dec 2018 | B2 |
10173094 | Gomberg | Jan 2019 | B2 |
10173095 | Gomberg et al. | Jan 2019 | B2 |
10173096 | Gomberg et al. | Jan 2019 | B2 |
10173097 | Gomberg et al. | Jan 2019 | B2 |
10198928 | Ross et al. | Feb 2019 | B1 |
10226663 | Gomberg et al. | Mar 2019 | B2 |
10231664 | Ganesh | Mar 2019 | B2 |
10244990 | Hu et al. | Apr 2019 | B2 |
10258823 | Cole | Apr 2019 | B2 |
10325070 | Beale et al. | Jun 2019 | B2 |
10327697 | Stein et al. | Jun 2019 | B1 |
10369021 | Zoss et al. | Aug 2019 | B2 |
10380866 | Ross et al. | Aug 2019 | B1 |
10413238 | Cooper | Sep 2019 | B1 |
10424033 | Romeo | Sep 2019 | B2 |
10430552 | Mihai | Oct 2019 | B2 |
D866957 | Ross et al. | Nov 2019 | S |
10468131 | Macoviak et al. | Nov 2019 | B2 |
10475323 | Ross | Nov 2019 | B1 |
10475537 | Purdie et al. | Nov 2019 | B2 |
10492977 | Kapure et al. | Dec 2019 | B2 |
10507358 | Kinnunen et al. | Dec 2019 | B2 |
10542914 | Forth et al. | Jan 2020 | B2 |
10546467 | Luciano, Jr. et al. | Jan 2020 | B1 |
10569122 | Johnson | Feb 2020 | B2 |
10572626 | Balram | Feb 2020 | B2 |
10576331 | Kuo | Mar 2020 | B2 |
10581896 | Nachenberg | Mar 2020 | B2 |
10625114 | Ercanbrack | Apr 2020 | B2 |
10646746 | Gomberg et al. | May 2020 | B1 |
10660534 | Lee et al. | May 2020 | B2 |
10678890 | Bitran et al. | Jun 2020 | B2 |
10685092 | Paparella et al. | Jun 2020 | B2 |
10777200 | Will et al. | Sep 2020 | B2 |
D899605 | Ross et al. | Oct 2020 | S |
10792495 | Izvorski et al. | Oct 2020 | B2 |
10867695 | Neagle | Dec 2020 | B2 |
10874905 | Belson et al. | Dec 2020 | B2 |
D907143 | Ach et al. | Jan 2021 | S |
10881911 | Kwon et al. | Jan 2021 | B2 |
10918332 | Belson et al. | Feb 2021 | B2 |
10931643 | Neumann | Feb 2021 | B1 |
10987176 | Poltaretskyi et al. | Apr 2021 | B2 |
10991463 | Kutzko et al. | Apr 2021 | B2 |
11000735 | Orady et al. | May 2021 | B2 |
11045709 | Putnam | Jun 2021 | B2 |
11065170 | Yang et al. | Jul 2021 | B2 |
11065527 | Putnam | Jul 2021 | B2 |
11069436 | Mason et al. | Jul 2021 | B2 |
11071597 | Posnack et al. | Jul 2021 | B2 |
11075000 | Mason et al. | Jul 2021 | B2 |
D928635 | Hacking et al. | Aug 2021 | S |
11087865 | Mason et al. | Aug 2021 | B2 |
11101028 | Mason et al. | Aug 2021 | B2 |
11107591 | Mason | Aug 2021 | B1 |
11139060 | Mason et al. | Oct 2021 | B2 |
11185735 | Arn et al. | Nov 2021 | B2 |
D939096 | Lee | Dec 2021 | S |
D939644 | Ach et al. | Dec 2021 | S |
D940797 | Ach et al. | Jan 2022 | S |
D940891 | Lee | Jan 2022 | S |
11229727 | Tatonetti | Jan 2022 | B2 |
11270795 | Mason et al. | Mar 2022 | B2 |
11272879 | Wiedenhoefer et al. | Mar 2022 | B2 |
11278766 | Lee | Mar 2022 | B2 |
11282599 | Mason et al. | Mar 2022 | B2 |
11282604 | Mason et al. | Mar 2022 | B2 |
11282608 | Mason et al. | Mar 2022 | B2 |
11284797 | Mason et al. | Mar 2022 | B2 |
D948639 | Ach et al. | Apr 2022 | S |
11295848 | Mason et al. | Apr 2022 | B2 |
11298284 | Bayerlein | Apr 2022 | B2 |
11309085 | Mason et al. | Apr 2022 | B2 |
11317975 | Mason et al. | May 2022 | B2 |
11325005 | Mason et al. | May 2022 | B2 |
11328807 | Mason et al. | May 2022 | B2 |
11337648 | Mason | May 2022 | B2 |
11348683 | Guaneri et al. | May 2022 | B2 |
11376470 | Weldemariam | Jul 2022 | B2 |
11404150 | Guaneri et al. | Aug 2022 | B2 |
11410768 | Mason et al. | Aug 2022 | B2 |
11422841 | Jeong | Aug 2022 | B2 |
11495355 | McNutt et al. | Nov 2022 | B2 |
11508258 | Nakashima et al. | Nov 2022 | B2 |
11508482 | Mason et al. | Nov 2022 | B2 |
11515021 | Mason | Nov 2022 | B2 |
11515028 | Mason | Nov 2022 | B2 |
11524210 | Kim et al. | Dec 2022 | B2 |
11527326 | McNair et al. | Dec 2022 | B2 |
11532402 | Farley et al. | Dec 2022 | B2 |
11534654 | Silcock et al. | Dec 2022 | B2 |
D976339 | Li | Jan 2023 | S |
11541274 | Hacking | Jan 2023 | B2 |
11636944 | Hanrahan et al. | Apr 2023 | B2 |
11663673 | Pyles | May 2023 | B2 |
11701548 | Posnack et al. | Jul 2023 | B2 |
20010044573 | Manoli | Nov 2001 | A1 |
20020072452 | Torkelson | Jun 2002 | A1 |
20020143279 | Porter et al. | Oct 2002 | A1 |
20020160883 | Dugan | Oct 2002 | A1 |
20030013072 | Thomas | Jan 2003 | A1 |
20030036683 | Kehr et al. | Feb 2003 | A1 |
20030064863 | Chen | Apr 2003 | A1 |
20030083596 | Kramer et al. | May 2003 | A1 |
20030181832 | Carnahan et al. | Sep 2003 | A1 |
20040102931 | Ellis et al. | May 2004 | A1 |
20040147969 | Mann et al. | Jul 2004 | A1 |
20040204959 | Moreano et al. | Oct 2004 | A1 |
20050043153 | Krietzman | Feb 2005 | A1 |
20050049122 | Vallone et al. | Mar 2005 | A1 |
20050115561 | Stahmann | Jun 2005 | A1 |
20060046905 | Doody, Jr. et al. | Mar 2006 | A1 |
20060058648 | Meier | Mar 2006 | A1 |
20060064136 | Wang | Mar 2006 | A1 |
20060064329 | Abolfathi et al. | Mar 2006 | A1 |
20060199700 | LaStayo et al. | Sep 2006 | A1 |
20070042868 | Fisher et al. | Feb 2007 | A1 |
20070118389 | Shipon | May 2007 | A1 |
20070137307 | Gruben et al. | Jun 2007 | A1 |
20070173392 | Stanford | Jul 2007 | A1 |
20070184414 | Perez | Aug 2007 | A1 |
20070194939 | Alvarez et al. | Aug 2007 | A1 |
20070219059 | Schwartz | Sep 2007 | A1 |
20070287597 | Cameron | Dec 2007 | A1 |
20080021834 | Holla et al. | Jan 2008 | A1 |
20080082356 | Friedlander et al. | Apr 2008 | A1 |
20080096726 | Riley et al. | Apr 2008 | A1 |
20080153592 | James-Herbert | Jun 2008 | A1 |
20080161733 | Einav et al. | Jul 2008 | A1 |
20080281633 | Burdea et al. | Nov 2008 | A1 |
20080300914 | Karkanias et al. | Dec 2008 | A1 |
20090011907 | Radow et al. | Jan 2009 | A1 |
20090058635 | LaLonde et al. | Mar 2009 | A1 |
20090070138 | Langheier et al. | Mar 2009 | A1 |
20090270227 | Ashby et al. | Oct 2009 | A1 |
20090287503 | Angell et al. | Nov 2009 | A1 |
20090299766 | Friedlander et al. | Dec 2009 | A1 |
20100048358 | Tchao et al. | Feb 2010 | A1 |
20100076786 | Dalton et al. | Mar 2010 | A1 |
20100121160 | Stark et al. | May 2010 | A1 |
20100173747 | Chen et al. | Jul 2010 | A1 |
20100216168 | Heinzman et al. | Aug 2010 | A1 |
20100248899 | Bedell et al. | Sep 2010 | A1 |
20100268304 | Matos | Oct 2010 | A1 |
20100298102 | Bosecker et al. | Nov 2010 | A1 |
20100326207 | Topel | Dec 2010 | A1 |
20110010188 | Yoshikawa et al. | Jan 2011 | A1 |
20110047108 | Chakrabarty et al. | Feb 2011 | A1 |
20110119212 | De Bruin et al. | May 2011 | A1 |
20110172059 | Watterson et al. | Jul 2011 | A1 |
20110195819 | Shaw et al. | Aug 2011 | A1 |
20110218814 | Coats | Sep 2011 | A1 |
20110275483 | Dugan | Nov 2011 | A1 |
20110306846 | Osorio | Dec 2011 | A1 |
20120041771 | Cosentino et al. | Feb 2012 | A1 |
20120065987 | Farooq et al. | Mar 2012 | A1 |
20120116258 | Lee | May 2012 | A1 |
20120183939 | Aragones et al. | Jul 2012 | A1 |
20120190502 | Paulus et al. | Jul 2012 | A1 |
20120232438 | Cataldi et al. | Sep 2012 | A1 |
20120259648 | Mallon et al. | Oct 2012 | A1 |
20120295240 | Walker et al. | Nov 2012 | A1 |
20120296455 | Ohnemus et al. | Nov 2012 | A1 |
20120310667 | Altman et al. | Dec 2012 | A1 |
20130123667 | Komatireddy et al. | May 2013 | A1 |
20130137550 | Skinner et al. | May 2013 | A1 |
20130178334 | Brammer | Jul 2013 | A1 |
20130211281 | Ross et al. | Aug 2013 | A1 |
20130253943 | Lee et al. | Sep 2013 | A1 |
20130274069 | Watterson et al. | Oct 2013 | A1 |
20130296987 | Rogers et al. | Nov 2013 | A1 |
20130318027 | Almogy et al. | Nov 2013 | A1 |
20130345025 | van der Merwe | Dec 2013 | A1 |
20140006042 | Keefe et al. | Jan 2014 | A1 |
20140011640 | Dugan | Jan 2014 | A1 |
20140089836 | Damani et al. | Mar 2014 | A1 |
20140113768 | Lin et al. | Apr 2014 | A1 |
20140155129 | Dugan | Jun 2014 | A1 |
20140172460 | Kohli | Jun 2014 | A1 |
20140188009 | Lange et al. | Jul 2014 | A1 |
20140194250 | Reich et al. | Jul 2014 | A1 |
20140194251 | Reich et al. | Jul 2014 | A1 |
20140207264 | Quy | Jul 2014 | A1 |
20140207486 | Carty et al. | Jul 2014 | A1 |
20140228649 | Rayner et al. | Aug 2014 | A1 |
20140246499 | Proud et al. | Sep 2014 | A1 |
20140256511 | Smith | Sep 2014 | A1 |
20140257837 | Walker et al. | Sep 2014 | A1 |
20140274565 | Boyette et al. | Sep 2014 | A1 |
20140274622 | Leonhard | Sep 2014 | A1 |
20140303540 | Baym | Oct 2014 | A1 |
20140309083 | Dugan | Oct 2014 | A1 |
20140315689 | Vauquelin et al. | Oct 2014 | A1 |
20140322686 | Kang | Nov 2014 | A1 |
20140371816 | Matos | Dec 2014 | A1 |
20150025816 | Ross | Jan 2015 | A1 |
20150045700 | Cavanagh et al. | Feb 2015 | A1 |
20150073814 | Linebaugh | Mar 2015 | A1 |
20150088544 | Goldberg | Mar 2015 | A1 |
20150094192 | Skwortsow et al. | Apr 2015 | A1 |
20150099458 | Weisner et al. | Apr 2015 | A1 |
20150099952 | Lain et al. | Apr 2015 | A1 |
20150141200 | Murray et al. | May 2015 | A1 |
20150151162 | Dugan | Jun 2015 | A1 |
20150158549 | Gros et al. | Jun 2015 | A1 |
20150161331 | Oleynik | Jun 2015 | A1 |
20150196805 | Koduri | Jul 2015 | A1 |
20150257679 | Ross | Sep 2015 | A1 |
20150265209 | Zhang | Sep 2015 | A1 |
20150290061 | Stafford et al. | Oct 2015 | A1 |
20150339442 | Oleynik | Nov 2015 | A1 |
20150351664 | Ross | Dec 2015 | A1 |
20150351665 | Ross | Dec 2015 | A1 |
20150360069 | Marti et al. | Dec 2015 | A1 |
20150379232 | Mainwaring et al. | Dec 2015 | A1 |
20150379430 | Dirac et al. | Dec 2015 | A1 |
20160007885 | Basta | Jan 2016 | A1 |
20160096073 | Rahman et al. | Apr 2016 | A1 |
20160117471 | Belt et al. | Apr 2016 | A1 |
20160140319 | Stark | May 2016 | A1 |
20160143593 | Fu et al. | May 2016 | A1 |
20160151670 | Dugan | Jun 2016 | A1 |
20160166881 | Ridgel et al. | Jun 2016 | A1 |
20160193306 | Rabovsky et al. | Jul 2016 | A1 |
20160213924 | Coleman | Jul 2016 | A1 |
20160275259 | Nolan et al. | Sep 2016 | A1 |
20160287166 | Tran | Oct 2016 | A1 |
20160302721 | Wiedenhoefer et al. | Oct 2016 | A1 |
20160317869 | Dugan | Nov 2016 | A1 |
20160322078 | Bose et al. | Nov 2016 | A1 |
20160325140 | Wu | Nov 2016 | A1 |
20160332028 | Melnik | Nov 2016 | A1 |
20160354636 | Jang | Dec 2016 | A1 |
20160361597 | Cole et al. | Dec 2016 | A1 |
20160373477 | Moyle | Dec 2016 | A1 |
20170004260 | Moturu et al. | Jan 2017 | A1 |
20170033375 | Ohmori et al. | Feb 2017 | A1 |
20170042467 | Herr et al. | Feb 2017 | A1 |
20170046488 | Pereira | Feb 2017 | A1 |
20170065851 | Deluca et al. | Mar 2017 | A1 |
20170080320 | Smith | Mar 2017 | A1 |
20170095670 | Ghaffari et al. | Apr 2017 | A1 |
20170095692 | Chang et al. | Apr 2017 | A1 |
20170095693 | Chang et al. | Apr 2017 | A1 |
20170100637 | Princen et al. | Apr 2017 | A1 |
20170106242 | Dugan | Apr 2017 | A1 |
20170128769 | Long et al. | May 2017 | A1 |
20170132947 | Maeda et al. | May 2017 | A1 |
20170136296 | Barrera et al. | May 2017 | A1 |
20170143261 | Wiedenhoefer et al. | May 2017 | A1 |
20170147789 | Wiedenhoefer et al. | May 2017 | A1 |
20170148297 | Ross | May 2017 | A1 |
20170168555 | Munoz et al. | Jun 2017 | A1 |
20170181698 | Wiedenhoefer et al. | Jun 2017 | A1 |
20170190052 | Jaekel et al. | Jul 2017 | A1 |
20170202724 | De Rossi | Jul 2017 | A1 |
20170209766 | Riley et al. | Jul 2017 | A1 |
20170220751 | Davis | Aug 2017 | A1 |
20170235882 | Orlov et al. | Aug 2017 | A1 |
20170235906 | Dorris et al. | Aug 2017 | A1 |
20170243028 | LaFever et al. | Aug 2017 | A1 |
20170262604 | Francois | Sep 2017 | A1 |
20170265800 | Auchinleck et al. | Sep 2017 | A1 |
20170266501 | Sanders et al. | Sep 2017 | A1 |
20170270260 | Shetty | Sep 2017 | A1 |
20170278209 | Olsen et al. | Sep 2017 | A1 |
20170282015 | Wicks et al. | Oct 2017 | A1 |
20170283508 | Demopulos et al. | Oct 2017 | A1 |
20170286621 | Cox | Oct 2017 | A1 |
20170300654 | Stein et al. | Oct 2017 | A1 |
20170304024 | Nobrega | Oct 2017 | A1 |
20170312614 | Tran et al. | Nov 2017 | A1 |
20170323481 | Tran et al. | Nov 2017 | A1 |
20170329917 | McRaith et al. | Nov 2017 | A1 |
20170333755 | Rider | Nov 2017 | A1 |
20170337033 | Duyan et al. | Nov 2017 | A1 |
20170337334 | Stanczak | Nov 2017 | A1 |
20170344726 | Duffy et al. | Nov 2017 | A1 |
20170347923 | Roh | Dec 2017 | A1 |
20170360586 | Dempers et al. | Dec 2017 | A1 |
20170368413 | Shavit | Dec 2017 | A1 |
20180017806 | Wang et al. | Jan 2018 | A1 |
20180036593 | Ridgel et al. | Feb 2018 | A1 |
20180052962 | Van Der Koijk et al. | Feb 2018 | A1 |
20180056104 | Cromie et al. | Mar 2018 | A1 |
20180060494 | Dias et al. | Mar 2018 | A1 |
20180071572 | Gomberg et al. | Mar 2018 | A1 |
20180075205 | Moturu et al. | Mar 2018 | A1 |
20180078843 | Tran et al. | Mar 2018 | A1 |
20180085615 | Astolfi et al. | Mar 2018 | A1 |
20180096111 | Wells et al. | Apr 2018 | A1 |
20180102190 | Hogue et al. | Apr 2018 | A1 |
20180116741 | Garcia Kilroy et al. | May 2018 | A1 |
20180146870 | Shemesh | May 2018 | A1 |
20180177612 | Trabish et al. | Jun 2018 | A1 |
20180178061 | O'larte et al. | Jun 2018 | A1 |
20180199855 | Odame et al. | Jul 2018 | A1 |
20180200577 | Dugan | Jul 2018 | A1 |
20180228682 | Bayerlein et al. | Aug 2018 | A1 |
20180240552 | Tuyl et al. | Aug 2018 | A1 |
20180253991 | Tang et al. | Sep 2018 | A1 |
20180256079 | Yang et al. | Sep 2018 | A1 |
20180263530 | Jung | Sep 2018 | A1 |
20180263535 | Cramer | Sep 2018 | A1 |
20180263552 | Graman et al. | Sep 2018 | A1 |
20180264312 | Pompile et al. | Sep 2018 | A1 |
20180271432 | Auchinleck et al. | Sep 2018 | A1 |
20180272184 | Vassilaros et al. | Sep 2018 | A1 |
20180280784 | Romeo et al. | Oct 2018 | A1 |
20180296143 | Anderson et al. | Oct 2018 | A1 |
20180296157 | Bleich et al. | Oct 2018 | A1 |
20180326243 | Badi et al. | Nov 2018 | A1 |
20180330058 | Bates | Nov 2018 | A1 |
20180330824 | Athey et al. | Nov 2018 | A1 |
20180290017 | Fung | Dec 2018 | A1 |
20180353812 | Lannon et al. | Dec 2018 | A1 |
20180360340 | Rehse et al. | Dec 2018 | A1 |
20190009135 | Wu | Jan 2019 | A1 |
20190019163 | Batey et al. | Jan 2019 | A1 |
20190019573 | Lake et al. | Jan 2019 | A1 |
20190019578 | Vaccaro | Jan 2019 | A1 |
20190030415 | Volpe, Jr. | Jan 2019 | A1 |
20190031284 | Fuchs | Jan 2019 | A1 |
20190046794 | Goodall | Feb 2019 | A1 |
20190060708 | Fung | Feb 2019 | A1 |
20190066832 | Kang et al. | Feb 2019 | A1 |
20190076701 | Dugan | Mar 2019 | A1 |
20190080802 | Ziobro et al. | Mar 2019 | A1 |
20190090744 | Mahfouz | Mar 2019 | A1 |
20190111299 | Radcliffe et al. | Apr 2019 | A1 |
20190115097 | Macoviak et al. | Apr 2019 | A1 |
20190118038 | Tana et al. | Apr 2019 | A1 |
20190126099 | Hoang | May 2019 | A1 |
20190132948 | Longinotti-Buitoni et al. | May 2019 | A1 |
20190134454 | Mahoney et al. | May 2019 | A1 |
20190137988 | Cella et al. | May 2019 | A1 |
20190167988 | Shahriari et al. | Jun 2019 | A1 |
20190172587 | Park et al. | Jun 2019 | A1 |
20190175988 | Volterrani et al. | Jun 2019 | A1 |
20190183715 | Kapure et al. | Jun 2019 | A1 |
20190200920 | Tien et al. | Jul 2019 | A1 |
20190209891 | Fung | Jul 2019 | A1 |
20190223797 | Tran | Jul 2019 | A1 |
20190240103 | Hepler et al. | Aug 2019 | A1 |
20190240541 | Denton et al. | Aug 2019 | A1 |
20190244540 | Errante et al. | Aug 2019 | A1 |
20190251456 | Constantin | Aug 2019 | A1 |
20190262084 | Roh | Aug 2019 | A1 |
20190269343 | Ramos Murguialday et al. | Sep 2019 | A1 |
20190274523 | Bates et al. | Sep 2019 | A1 |
20190275368 | Maroldi | Sep 2019 | A1 |
20190290964 | Oren | Sep 2019 | A1 |
20190304584 | Savolainen | Oct 2019 | A1 |
20190307983 | Goldman | Oct 2019 | A1 |
20190314681 | Yang | Oct 2019 | A1 |
20190344123 | Rubin et al. | Nov 2019 | A1 |
20190354632 | Mital et al. | Nov 2019 | A1 |
20190362242 | Pillai et al. | Nov 2019 | A1 |
20190366146 | Tong et al. | Dec 2019 | A1 |
20190388728 | Wang et al. | Dec 2019 | A1 |
20200005928 | Daniel | Jan 2020 | A1 |
20200038703 | Cleary et al. | Feb 2020 | A1 |
20200051446 | Rubinstein et al. | Feb 2020 | A1 |
20200066390 | Svendrys et al. | Feb 2020 | A1 |
20200085300 | Kwatra et al. | Mar 2020 | A1 |
20200093418 | Kluger et al. | Mar 2020 | A1 |
20200143922 | Chekroud et al. | May 2020 | A1 |
20200151595 | Jayalath et al. | May 2020 | A1 |
20200151646 | De La Fuente Sanchez | May 2020 | A1 |
20200152339 | Pulitzer et al. | May 2020 | A1 |
20200160198 | Reeves et al. | May 2020 | A1 |
20200170876 | Kapure et al. | Jun 2020 | A1 |
20200176098 | Lucas et al. | Jun 2020 | A1 |
20200197744 | Schweighofer | Jun 2020 | A1 |
20200221975 | Basta et al. | Jul 2020 | A1 |
20200267487 | Siva | Aug 2020 | A1 |
20200275886 | Mason | Sep 2020 | A1 |
20200289045 | Hacking et al. | Sep 2020 | A1 |
20200289046 | Hacking et al. | Sep 2020 | A1 |
20200289879 | Hacking et al. | Sep 2020 | A1 |
20200289880 | Hacking et al. | Sep 2020 | A1 |
20200289881 | Hacking et al. | Sep 2020 | A1 |
20200289889 | Hacking et al. | Sep 2020 | A1 |
20200293712 | Potts et al. | Sep 2020 | A1 |
20200303063 | Sharma et al. | Sep 2020 | A1 |
20200334972 | Gopalakrishnan | Oct 2020 | A1 |
20200357299 | Patel et al. | Nov 2020 | A1 |
20200365256 | Hayashitani et al. | Nov 2020 | A1 |
20200395112 | Ronner | Dec 2020 | A1 |
20200401224 | Cotton | Dec 2020 | A1 |
20200410385 | Otsuki | Dec 2020 | A1 |
20200411162 | Lien et al. | Dec 2020 | A1 |
20210005224 | Rothschild et al. | Jan 2021 | A1 |
20210005319 | Otsuki et al. | Jan 2021 | A1 |
20210035674 | Volosin et al. | Feb 2021 | A1 |
20210074178 | Ilan et al. | Mar 2021 | A1 |
20210076981 | Hacking et al. | Mar 2021 | A1 |
20210077860 | Posnack et al. | Mar 2021 | A1 |
20210098129 | Neumann | Apr 2021 | A1 |
20210101051 | Posnack et al. | Apr 2021 | A1 |
20210113890 | Posnack et al. | Apr 2021 | A1 |
20210127974 | Mason et al. | May 2021 | A1 |
20210128080 | Mason et al. | May 2021 | A1 |
20210128255 | Mason et al. | May 2021 | A1 |
20210128978 | Gilstrom et al. | May 2021 | A1 |
20210134412 | Guaneri et al. | May 2021 | A1 |
20210134425 | Mason et al. | May 2021 | A1 |
20210134428 | Mason et al. | May 2021 | A1 |
20210134430 | Mason et al. | May 2021 | A1 |
20210134432 | Mason et al. | May 2021 | A1 |
20210134456 | Posnack et al. | May 2021 | A1 |
20210134457 | Mason et al. | May 2021 | A1 |
20210134458 | Mason et al. | May 2021 | A1 |
20210134463 | Mason et al. | May 2021 | A1 |
20210138304 | Mason et al. | May 2021 | A1 |
20210142875 | Mason et al. | May 2021 | A1 |
20210142893 | Guaneri et al. | May 2021 | A1 |
20210142898 | Mason et al. | May 2021 | A1 |
20210142903 | Mason et al. | May 2021 | A1 |
20210144074 | Guaneri et al. | May 2021 | A1 |
20210186419 | Van Ee et al. | Jun 2021 | A1 |
20210202090 | ODonovan et al. | Jul 2021 | A1 |
20210202103 | Bostic et al. | Jul 2021 | A1 |
20210244998 | Hacking et al. | Aug 2021 | A1 |
20210245003 | Turner | Aug 2021 | A1 |
20210272677 | Barbee | Sep 2021 | A1 |
20210338469 | Dempers | Nov 2021 | A1 |
20210343384 | Purushothaman et al. | Nov 2021 | A1 |
20210345879 | Mason et al. | Nov 2021 | A1 |
20210345975 | Mason et al. | Nov 2021 | A1 |
20210350888 | Guaneri et al. | Nov 2021 | A1 |
20210350898 | Mason et al. | Nov 2021 | A1 |
20210350899 | Mason et al. | Nov 2021 | A1 |
20210350901 | Mason et al. | Nov 2021 | A1 |
20210350902 | Mason et al. | Nov 2021 | A1 |
20210350914 | Guaneri et al. | Nov 2021 | A1 |
20210350926 | Mason et al. | Nov 2021 | A1 |
20210361514 | Choi et al. | Nov 2021 | A1 |
20210366587 | Mason et al. | Nov 2021 | A1 |
20210383909 | Mason et al. | Dec 2021 | A1 |
20210391091 | Mason | Dec 2021 | A1 |
20210398668 | Chock et al. | Dec 2021 | A1 |
20210407670 | Mason et al. | Dec 2021 | A1 |
20210407681 | Mason et al. | Dec 2021 | A1 |
20220000556 | Casey et al. | Jan 2022 | A1 |
20220016480 | Bissonnette et al. | Jan 2022 | A1 |
20220016482 | Bissonnette | Jan 2022 | A1 |
20220016485 | Bissonnette et al. | Jan 2022 | A1 |
20220016486 | Bissonnette | Jan 2022 | A1 |
20220020469 | Tanner | Jan 2022 | A1 |
20220044806 | Sanders et al. | Feb 2022 | A1 |
20220047921 | Bissonnette et al. | Feb 2022 | A1 |
20220079690 | Mason et al. | Mar 2022 | A1 |
20220080256 | Am et al. | Mar 2022 | A1 |
20220080265 | Watterson | Mar 2022 | A1 |
20220105384 | Hacking et al. | Apr 2022 | A1 |
20220105385 | Hacking et al. | Apr 2022 | A1 |
20220105390 | Yuasa | Apr 2022 | A1 |
20220115133 | Mason et al. | Apr 2022 | A1 |
20220118218 | Bense et al. | Apr 2022 | A1 |
20220126169 | Mason | Apr 2022 | A1 |
20220133576 | Choi et al. | May 2022 | A1 |
20220148725 | Mason et al. | May 2022 | A1 |
20220158916 | Mason et al. | May 2022 | A1 |
20220176039 | Lintereur et al. | Jun 2022 | A1 |
20220181004 | Zilca et al. | Jun 2022 | A1 |
20220193491 | Mason et al. | Jun 2022 | A1 |
20220230729 | Mason et al. | Jul 2022 | A1 |
20220238222 | Neuberg | Jul 2022 | A1 |
20220238223 | Mason et al. | Jul 2022 | A1 |
20220262483 | Rosenberg et al. | Aug 2022 | A1 |
20220262504 | Bratty et al. | Aug 2022 | A1 |
20220266094 | Mason et al. | Aug 2022 | A1 |
20220270738 | Mason et al. | Aug 2022 | A1 |
20220273985 | Jeong et al. | Sep 2022 | A1 |
20220273986 | Mason | Sep 2022 | A1 |
20220288460 | Mason | Sep 2022 | A1 |
20220288461 | Ashley et al. | Sep 2022 | A1 |
20220288462 | Ashley et al. | Sep 2022 | A1 |
20220293257 | Guaneri et al. | Sep 2022 | A1 |
20220300787 | Wall et al. | Sep 2022 | A1 |
20220304881 | Choi et al. | Sep 2022 | A1 |
20220304882 | Choi | Sep 2022 | A1 |
20220305328 | Choi et al. | Sep 2022 | A1 |
20220314075 | Mason et al. | Oct 2022 | A1 |
20220323826 | Khurana | Oct 2022 | A1 |
20220327714 | Cook et al. | Oct 2022 | A1 |
20220327807 | Cook et al. | Oct 2022 | A1 |
20220328181 | Mason et al. | Oct 2022 | A1 |
20220330823 | Janssen | Oct 2022 | A1 |
20220331663 | Mason | Oct 2022 | A1 |
20220338761 | Maddahi et al. | Oct 2022 | A1 |
20220339052 | Kim | Oct 2022 | A1 |
20220339501 | Mason et al. | Oct 2022 | A1 |
20220384012 | Mason | Dec 2022 | A1 |
20220392591 | Guaneri et al. | Dec 2022 | A1 |
20220395232 | Locke | Dec 2022 | A1 |
20220401783 | Choi | Dec 2022 | A1 |
20220415469 | Mason | Dec 2022 | A1 |
20220415471 | Mason | Dec 2022 | A1 |
20230001268 | Bissonnette et al. | Jan 2023 | A1 |
20230013530 | Mason | Jan 2023 | A1 |
20230014598 | Mason et al. | Jan 2023 | A1 |
20230029639 | Roy | Feb 2023 | A1 |
20230048040 | Hacking et al. | Feb 2023 | A1 |
20230051751 | Hacking et al. | Feb 2023 | A1 |
20230058605 | Mason | Feb 2023 | A1 |
20230060039 | Mason | Feb 2023 | A1 |
20230072368 | Mason | Mar 2023 | A1 |
20230078793 | Mason | Mar 2023 | A1 |
20230119461 | Mason | Apr 2023 | A1 |
20230190100 | Stump | Jun 2023 | A1 |
20230201656 | Hacking et al. | Jun 2023 | A1 |
20230207097 | Mason | Jun 2023 | A1 |
20230207124 | Walsh et al. | Jun 2023 | A1 |
20230215539 | Rosenberg et al. | Jul 2023 | A1 |
20230215552 | Khotilovich et al. | Jul 2023 | A1 |
20230245747 | Rosenberg et al. | Aug 2023 | A1 |
20230245748 | Rosenberg et al. | Aug 2023 | A1 |
20230245750 | Rosenberg et al. | Aug 2023 | A1 |
20230245751 | Rosenberg et al. | Aug 2023 | A1 |
20230253089 | Rosenberg et al. | Aug 2023 | A1 |
20230255555 | Sundaram et al. | Aug 2023 | A1 |
20230263428 | Hull et al. | Aug 2023 | A1 |
20230274813 | Rosenberg et al. | Aug 2023 | A1 |
20230282329 | Mason et al. | Sep 2023 | A1 |
20240029856 | Rosenberg | Jan 2024 | A1 |
Number | Date | Country |
---|---|---|
2698078 | Mar 2010 | CA |
3193419 | Mar 2022 | CA |
2885238 | Apr 2007 | CN |
101964151 | Feb 2011 | CN |
201889024 | Jul 2011 | CN |
102670381 | Sep 2012 | CN |
103263336 | Aug 2013 | CN |
103390357 | Nov 2013 | CN |
103473631 | Dec 2013 | CN |
103488880 | Jan 2014 | CN |
103501328 | Jan 2014 | CN |
103721343 | Apr 2014 | CN |
203677851 | Jul 2014 | CN |
104335211 | Feb 2015 | CN |
105683977 | Jun 2016 | CN |
103136447 | Aug 2016 | CN |
105894088 | Aug 2016 | CN |
105930668 | Sep 2016 | CN |
205626871 | Oct 2016 | CN |
106127646 | Nov 2016 | CN |
106236502 | Dec 2016 | CN |
106510985 | Mar 2017 | CN |
106621195 | May 2017 | CN |
107066819 | Aug 2017 | CN |
107430641 | Dec 2017 | CN |
107551475 | Jan 2018 | CN |
107736982 | Feb 2018 | CN |
107930021 | Apr 2018 | CN |
108078737 | May 2018 | CN |
208224811 | Dec 2018 | CN |
109191954 | Jan 2019 | CN |
109363887 | Feb 2019 | CN |
208573971 | Mar 2019 | CN |
110148472 | Aug 2019 | CN |
110201358 | Sep 2019 | CN |
110215188 | Sep 2019 | CN |
110322957 | Oct 2019 | CN |
110808092 | Feb 2020 | CN |
110931103 | Mar 2020 | CN |
110993057 | Apr 2020 | CN |
111105859 | May 2020 | CN |
111111110 | May 2020 | CN |
111370088 | Jul 2020 | CN |
111460305 | Jul 2020 | CN |
111790111 | Oct 2020 | CN |
112071393 | Dec 2020 | CN |
212141371 | Dec 2020 | CN |
112289425 | Jan 2021 | CN |
212624809 | Feb 2021 | CN |
112603295 | Apr 2021 | CN |
213190965 | May 2021 | CN |
113384850 | Sep 2021 | CN |
113499572 | Oct 2021 | CN |
215136488 | Dec 2021 | CN |
113885361 | Jan 2022 | CN |
114049961 | Feb 2022 | CN |
114203274 | Mar 2022 | CN |
216258145 | Apr 2022 | CN |
114632302 | Jun 2022 | CN |
114694824 | Jul 2022 | CN |
114898832 | Aug 2022 | CN |
114983760 | Sep 2022 | CN |
217472652 | Sep 2022 | CN |
110270062 | Oct 2022 | CN |
218420859 | Feb 2023 | CN |
115954081 | Apr 2023 | CN |
102018202497 | Aug 2018 | DE |
102018211212 | Jan 2019 | DE |
102019108425 | Aug 2020 | DE |
0383137 | Aug 1990 | EP |
1159989 | Dec 2001 | EP |
1391179 | Feb 2004 | EP |
1968028 | Sep 2008 | EP |
1909730 | Apr 2014 | EP |
2815242 | Dec 2014 | EP |
2869805 | May 2015 | EP |
2997951 | Mar 2016 | EP |
2688472 | Apr 2016 | EP |
3264303 | Jan 2018 | EP |
3323473 | May 2018 | EP |
3627514 | Mar 2020 | EP |
3671700 | Jun 2020 | EP |
3688537 | Aug 2020 | EP |
3731733 | Nov 2020 | EP |
3984508 | Apr 2022 | EP |
3984509 | Apr 2022 | EP |
3984510 | Apr 2022 | EP |
3984511 | Apr 2022 | EP |
3984512 | Apr 2022 | EP |
3984513 | Apr 2022 | EP |
4054699 | Sep 2022 | EP |
4112033 | Jan 2023 | EP |
3127393 | Mar 2023 | FR |
2512431 | Oct 2014 | GB |
2591542 | Mar 2022 | GB |
201811043670 | Jul 2018 | IN |
2000005339 | Jan 2000 | JP |
2003225875 | Aug 2003 | JP |
2005227928 | Aug 2005 | JP |
2005227928 | Aug 2005 | JP |
2009112336 | May 2009 | JP |
2013515995 | May 2013 | JP |
3193662 | Oct 2014 | JP |
3198173 | Jun 2015 | JP |
5804063 | Nov 2015 | JP |
6659831 | Oct 2017 | JP |
2018102842 | Jul 2018 | JP |
2019028647 | Feb 2019 | JP |
2019134909 | Aug 2019 | JP |
6573739 | Sep 2019 | JP |
6710357 | Jun 2020 | JP |
6775757 | Oct 2020 | JP |
2021026768 | Feb 2021 | JP |
2021027917 | Feb 2021 | JP |
6871379 | May 2021 | JP |
2022521378 | Apr 2022 | JP |
3238491 | Jul 2022 | JP |
7198364 | Dec 2022 | JP |
7202474 | Jan 2023 | JP |
7231750 | Mar 2023 | JP |
7231751 | Mar 2023 | JP |
7231752 | Mar 2023 | JP |
20020009724 | Feb 2002 | KR |
200276919 | May 2002 | KR |
20020065253 | Aug 2002 | KR |
100582596 | May 2006 | KR |
101042258 | Jun 2011 | KR |
101258250 | Apr 2013 | KR |
20140128630 | Nov 2014 | KR |
20150017693 | Feb 2015 | KR |
20150078191 | Jul 2015 | KR |
101580071 | Dec 2015 | KR |
101647620 | Aug 2016 | KR |
20160093990 | Aug 2016 | KR |
20170038837 | Apr 2017 | KR |
20180004928 | Jan 2018 | KR |
20190011885 | Feb 2019 | KR |
20190029175 | Mar 2019 | KR |
101988167 | Jun 2019 | KR |
102116664 | Jul 2019 | KR |
101969392 | Aug 2019 | KR |
102055279 | Dec 2019 | KR |
102088333 | Mar 2020 | KR |
102116968 | Mar 2020 | KR |
20200025290 | Mar 2020 | KR |
20200029180 | Mar 2020 | KR |
102162522 | Apr 2020 | KR |
102142713 | May 2020 | KR |
20200056233 | May 2020 | KR |
102120828 | Jun 2020 | KR |
102121586 | Jun 2020 | KR |
20200119665 | Oct 2020 | KR |
102173553 | Nov 2020 | KR |
102180079 | Nov 2020 | KR |
102224618 | Nov 2020 | KR |
102188766 | Dec 2020 | KR |
102196793 | Dec 2020 | KR |
20210006212 | Jan 2021 | KR |
102224188 | Mar 2021 | KR |
102246049 | Apr 2021 | KR |
102246050 | Apr 2021 | KR |
102246051 | Apr 2021 | KR |
102246052 | Apr 2021 | KR |
20210052028 | May 2021 | KR |
102264498 | Jun 2021 | KR |
102352602 | Jan 2022 | KR |
102352603 | Jan 2022 | KR |
102352604 | Jan 2022 | KR |
20220004639 | Jan 2022 | KR |
102387577 | Apr 2022 | KR |
102421437 | Jul 2022 | KR |
20220102207 | Jul 2022 | KR |
102427545 | Aug 2022 | KR |
102467495 | Nov 2022 | KR |
102467496 | Nov 2022 | KR |
102469723 | Nov 2022 | KR |
102471990 | Nov 2022 | KR |
20220145989 | Nov 2022 | KR |
20220156134 | Nov 2022 | KR |
102502744 | Feb 2023 | KR |
20230019349 | Feb 2023 | KR |
20230019350 | Feb 2023 | KR |
20230026556 | Feb 2023 | KR |
20230026668 | Feb 2023 | KR |
20230040526 | Mar 2023 | KR |
20230050506 | Apr 2023 | KR |
20230056118 | Apr 2023 | KR |
102528503 | May 2023 | KR |
102531930 | May 2023 | KR |
102532766 | May 2023 | KR |
102539190 | Jun 2023 | KR |
2014131288 | Feb 2016 | RU |
2607953 | Jan 2017 | RU |
M474545 | Mar 2014 | TW |
M638437 | Mar 2023 | TW |
0149235 | Jul 2001 | WO |
0151083 | Jul 2001 | WO |
2001050387 | Jul 2001 | WO |
2001056465 | Aug 2001 | WO |
02062211 | Aug 2002 | WO |
02093312 | Nov 2002 | WO |
2003043494 | May 2003 | WO |
2005018453 | Mar 2005 | WO |
2006004430 | Jan 2006 | WO |
2007102709 | Sep 2007 | WO |
2008114291 | Sep 2008 | WO |
2009008968 | Jan 2009 | WO |
2011025322 | Mar 2011 | WO |
2012128801 | Sep 2012 | WO |
2013002568 | Jan 2013 | WO |
2023164292 | Mar 2013 | WO |
2013122839 | Aug 2013 | WO |
2014011447 | Jan 2014 | WO |
2014163976 | Oct 2014 | WO |
2015026744 | Feb 2015 | WO |
2015065298 | May 2015 | WO |
2015082555 | Jun 2015 | WO |
2016154318 | Sep 2016 | WO |
2017030781 | Feb 2017 | WO |
2017166074 | May 2017 | WO |
2017091691 | Jun 2017 | WO |
2017165238 | Sep 2017 | WO |
2018081795 | May 2018 | WO |
2018171853 | Sep 2018 | WO |
2019022706 | Jan 2019 | WO |
2019204876 | Apr 2019 | WO |
2019143940 | Jul 2019 | WO |
2020185769 | Mar 2020 | WO |
2020075190 | Apr 2020 | WO |
2020130979 | Jun 2020 | WO |
2020149815 | Jul 2020 | WO |
2020229705 | Nov 2020 | WO |
2020245727 | Dec 2020 | WO |
2020249855 | Dec 2020 | WO |
2020252599 | Dec 2020 | WO |
2020256577 | Dec 2020 | WO |
2021021447 | Feb 2021 | WO |
2021022003 | Feb 2021 | WO |
2021038980 | Mar 2021 | WO |
2021055427 | Mar 2021 | WO |
2021055491 | Mar 2021 | WO |
2021061061 | Apr 2021 | WO |
2021081094 | Apr 2021 | WO |
2021090267 | May 2021 | WO |
2021138620 | Jul 2021 | WO |
2021216881 | Oct 2021 | WO |
2021236542 | Nov 2021 | WO |
2021236961 | Nov 2021 | WO |
2021262809 | Dec 2021 | WO |
2022047006 | Mar 2022 | WO |
2022092493 | May 2022 | WO |
2022092494 | May 2022 | WO |
2022212883 | Oct 2022 | WO |
2022212921 | Oct 2022 | WO |
2022216498 | Oct 2022 | WO |
2022251420 | Dec 2022 | WO |
2023008680 | Feb 2023 | WO |
2023008681 | Feb 2023 | WO |
2023022319 | Feb 2023 | WO |
2023022320 | Feb 2023 | WO |
2023052695 | Apr 2023 | WO |
2023091496 | May 2023 | WO |
Entry |
---|
International Search Report and Written Opinion for International Application No. PCT/US2021/032807, dated Sep. 6, 2021, 11 pages. |
Claris Healthcare, Inc., Claris Reflex Patient Rehabilitation System Brochure, https://clarisreflex.com/, retrieved from Internet on Oct. 2, 2019, five page. |
International Searching Authority, Search Report and Written Opinion for International Application No. PCT/US20/51008, dated Dec. 10, 2020, nine pages. |
Jennifer Bresnick, “What is the Role of Natural Language Processing in Healthcare?”, pp. 1-7, published Aug. 18, 2016, retrieved on Feb. 1, 2022 from https://healthitanalytics.com/ featu res/what-is-the-role-of-natural-language-processing-in-healthcare. |
Alex Bellec, “Part-of-Speech tagging tutorial with the Keras Deep Learning library,” pp. 1-16, published Mar. 27, 2018, retrieved on Feb. 1, 2022 from https://becominghuman.ai/part-of-speech-tagging-tutorial-with-the-keras-deep-learning-library-d7f93fa05537. |
Kavita Ganesan, All you need to know about text preprocessing for NLP and Machine Learning, pp. 1-14, published Feb. 23, 2019, retrieved on Feb. 1, 2022 from https:// towardsdatascience.com/all-you-need-to-know-about-text-preprocessing-for-nlp-and-machine-learning-bcl c5765ff67. |
Badreesh Shetty, “Natural Language Processing (NPL) for Machine Learning,” pp. 1-13, published Nov. 24, 2018, retrieved on Feb. 1, 2022 from https://towardsdatascience. com/natural-language-processing-nlp-for-machine-learning-d44498845d5b. |
Malloy, Online Article “AI-enabled EKGs find difference between numerical age and biological age significantly affects health, longevity”, Website: https://newsnetwork.mayoclinic.org/discussion/ai-enabled-ekgs-find-difference-between-numerical-age-and-biological-age-significantly-affects-health-longevity/, Mayo Clinic News Network, May 20, 2021, retrieved: Jan. 23, 2023, p. 1-4. |
Website for “Pedal Exerciser”, p. 1, retrieved on Sep. 9, 2022 from https://www.vivehealth.com/collections/physical-therapy-equipment/products/pedalexerciser. |
Website for “Functional Knee Brace with ROM”, p. 1, retrieved on Sep. 9, 2022 from http://medicalbrace.gr/en/product/functional-knee-brace-with-goniometer-mbtelescopicknee/. |
Website for “ComfySplints Goniometer Knee”, pp. 1-5, retrieved on Sep. 9, 2022 from https://www.comfysplints.com/product/knee-splints/. |
Website for “BMI FlexEze Knee Corrective Orthosis (KCO)”, pp. 1-4, retrieved on Sep. 9, 2022 from https://orthobmi.com/products/bmi-flexeze%C2%AE-knee-corrective-orthosis-kco. |
Website for “Neoprene Knee Brace with goniometer—Patella ROM MB.4070”, pp. 1-4, retrieved on Sep. 9, 2022 from https://www.fortuna.com.gr/en/product/neoprene-knee-brace-with-goniometer-patella-rom-mb-4070/. |
Kuiken et al., “Computerized Biofeedback Knee Goniometer: Acceptance and Effect on Exercise Behavior in Post-total Knee Arthroplasty Rehabilitation,” Biomedical Engineering Faculty Research and Publications, 2004, pp. 1-10. |
Ahmed et al., “Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine,” Database, 2020, pp. 1-35. |
Davenport et al., “The potential for artificial intelligence in healthcare,” Digital Technology, Future Healthcare Journal, 2019, pp. 1-5, vol. 6, No. 2. |
Website for “OxeFit XS1”, pp. 1-3, retrieved on Sep. 9, 2022 from https://www.oxefit.com/xs1. |
Website for “Preva Mobile”, pp. 1-6, retrieved on Sep. 9, 2022 from https://www.precor.com/en-us/resources/introducing-preva-mobile. |
Website for “J-Bike”, pp. 1-3, retrieved on Sep. 9, 2022 from https://www.magneticdays.com/en/cycling-for-physical-rehabilitation. |
Website for “Excy”, pp. 1-12, retrieved on Sep. 9, 2022 from https://excy.com/portable-exercise-rehabilitation-excy-xcs-pro/. |
Website for “OxeFit XP1”, p. 1, retrieved on Sep. 9, 2022 from https://www.oxefit.com/xp1. |
Jeong et al., “Computer-assisted upper extremity training using interactive biking exercise (iBikE) platform,” Sep. 2012, pp. 1-5, 34th Annual International Conference of the IEEE EMBS. |
Davenport et al., “The Potential for Artificial Intelligence in Healthcare”, 2019, Future Healthcare Journal 2019, vol. 6, No. 2: Year: 2019, pp. 1-5. |
Ahmed et al., “Artificial Intelligence With Multi-Functional Machine Learning Platform Development for Better Healthcare and Precision Medicine”, 2020, Database (Oxford), 2020:baaa010. doi: 10.1093/database/baaa010 (Year: 2020), pp. 1-35. |
Ruiz Ivan et al., “Towards a physical rehabilitation system using a telemedicine approach”, Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization, vol. 8, No. 6, Jul. 28, 2020, pp. 671-680, XP055914810. |
De Canniere Helene et al., “Wearable Monitoring and Interpretable Machine Learning Can Objectively Track Progression in Patients during Cardiac Rehabilitation”, Sensors, vol. 20, No. 12, Jun. 26, 2020, XP055914617, pp. 1-15. |
Boulanger Pierre et al., “A Low-cost Virtual Reality Bike for Remote Cardiac Rehabilitation”, Dec. 7, 2017, Advances in Biometrics: International Conference, ICB 2007, Seoul, Korea, pp. 155-166. |
Yin Chieh et al., “A Virtual Reality-Cycling Training System for Lower Limb Balance Improvement”, BioMed Research International, vol. 2016, pp. 1-10. |
Barrett et al., “Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care,” EPMA Journal (2019), pp. 445-464. |
Oerkild et al., “Home-based cardiac rehabilitation is an attractive alternative to no cardiac rehabilitation for elderly patients with coronary heart disease: results from a randomised clinical trial,” BMJ Open Accessible Medical Research, Nov. 22, 2012, pp. 1-9. |
Bravo-Escobar et al., “Effectiveness and safety of a home-based cardiac rehabilitation programme of mixed surveillance in patients with ischemic heart disease at moderate cardiovascular risk: A randomised, controlled clinical trial,” BMC Cardiovascular Disorders, 2017, pp. 1-11, vol. 17:66. |
Thomas et al., “Home-Based Cardiac Rehabilitation,” Circulation, 2019, pp. e69-e89, vol. 140. |
Thomas et al., “Home-Based Cardiac Rehabilitation,” Journal of the American College of Cardiology, Nov. 1, 2019, pp. 133-153, vol. 74. |
Thomas et al., “Home-Based Cardiac Rehabilitation,” HHS Public Access, Oct. 2, 2020, pp. 1-39. |
Dittus et al., “Exercise-Based Oncology Rehabilitation: Leveraging the Cardiac Rehabilitation Model,” Journal of Cardiopulmonary Rehabilitation and Prevention, 2015, pp. 130-139, vol. 35. |
Chen et al., “Home-based cardiac rehabilitation improves quality of life, aerobic capacity, and readmission rates in patients with chronic heart failure,” Medicine, 2018, pp. 1-5 vol. 97:4. |
Lima de Melo Ghisi et al., “A systematic review of patient education in cardiac patients: Do they increase knowledge and promote health behavior change?,” Patient Education and Counseling, 2014, pp. 1-15. |
Fang et al., “Use of Outpatient Cardiac Rehabilitation Among Heart Attack Survivors—20 States and the District of Columbia, 2013 and Four States, 2015,” Morbidity and Mortality Weekly Report, vol. 66, No. 33, Aug. 25, 2017, pp. 869-873. |
Beene et al., “AI and Care Delivery: Emerging Opportunities for Artificial Intelligence to Transform How Care Is Delivered,” Nov. 2019, American Hospital Association, pp. 1-12. |
International Search Report and Written Opinion for PCT/US2023/014137, dated Jun. 9, 2023, 13 pages. |
Website for “Esino 2022 Physical Therapy Equipments Arm Fitness Indoor Trainer Leg Spin Cycle Machine Exercise Bike for Elderly,” https://www.made-in-china.com/showroom/esinogroup/product-detailYdZtwGhCMKVR/China-Esino-2022-Physical-Therapy-Equipments-Arm-Fitness-Indoor-Trainer-Leg-Spin-Cycle-Machine-Exercise-Bike-for-Elderly.html, retrieved on Aug. 29, 2023, 5 pages. |
Abedtash, “An Interoperable Electronic Medical Record-Based Platform for Personalized Predictive Analytics”, ProQuest LLC, Jul. 2017, 185 pages. |
Alcaraz et al., “Machine Learning as Digital Therapy Assessment for Mobile Gait Rehabilitation,” 2018 IEEE 28th International Workshop on Machine Learning for Signal Processing (MLSP), Aalborg, Denmark, 2018, 6 pages. |
Androutsou et al., “A Smartphone Application Designed to Engage the Elderly in Home-Based Rehabilitation,” Frontiers in Digital Health, Sep. 2020, vol. 2, Article 15, 13 pages. |
Silva et al., “SapoFitness: A mobile health application for dietary evaluation,” 2011 IEEE 13th International Conference on U e-Health Networking, Applications and Services, Columbia, MO, USA, 2011, 6 pages. |
Wang et al., “Interactive wearable systems for upper body rehabilitation: a systematic review,” Journal of NeuroEngineering and Rehabilitation, 2017, 21 pages. |
Marzolini et al., “Eligibility, Enrollment, and Completion of Exercise-Based Cardiac Rehabilitation Following Stroke Rehabilitation: What Are the Barriers?,” Physical Therapy, vol. 100, No. 1, 2019, 13 pages. |
Nijjar et al., “Randomized Trial of Mindfulness-Based Stress Reduction in Cardiac Patients Eligible for Cardiac Rehabilitation,” Scientific Reports, 2019, 12 pages. |
Lara et al., “Human-Robot Sensor Interface for Cardiac Rehabilitation,” IEEE International Conference on Rehabilitation Robotics, Jul. 2017, 8 pages. |
Ishraque et al., “Artificial Intelligence-Based Rehabilitation Therapy Exercise Recommendation System,” 2018 IEEE MIT Undergraduate Research Technology Conference (URTC), Cambridge, MA, USA, 2018, 5 pages. |
Zakari et al., “Are There Limitations to Exercise Benefits in Peripheral Arterial Disease?,” Frontiers in Cardiovascular Medicine, Nov. 2018, vol. 5, Article 173, 12 pages. |
You et al., “Including Blood Vasculature into a Game-Theoretic Model of Cancer Dynamics,” Games 2019, 10, 13, 22 pages. |
Jeong et al., “Computer-assisted upper extremity training using interactive biking exercise (iBikE) platform,” Sep. 2012, 34th Annual International Conference of the IEEE EMBS, 5 pages. |
Chrif et al., “Control design for a lower-limb paediatric therapy device using linear motor technology,” Article, 2017, pp. 119-127, Science Direct, Switzerland. |
Robben et al., “Delta Features From Ambient Sensor Data are Good Predictors of Change in Functional Health,” Article, 2016, pp. 2168-2194, vol. 21, No. 4, IEEE Journal of Biomedical and Health Informatics. |
Kantoch et al., “Recognition of Sedentary Behavior by Machine Learning Analysis of Wearable Sensors during Activities of Daily Living for Telemedical Assessment of Cardiovascular Risk,” Article, 2018, 17 pages, Sensors, Poland. |
Warburton et al., “International Launch of the Par-·Q+ And ePARmed-·X+ Validation of the PAR-·Q+ and ePARmed··X+,” Health & Fitness Journal of Canada, 2011, 9 pages, vol. 4, No. 2. |
Number | Date | Country | |
---|---|---|---|
20220015838 A1 | Jan 2022 | US |
Number | Date | Country | |
---|---|---|---|
62910232 | Oct 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17021895 | Sep 2020 | US |
Child | 17385473 | US |